chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a physician via call center representative and described the occurrence of fever in a 22-year-old female patient who received BEXSERO for prophylaxis. Concurrent medical conditions included heavy periods. Concomitant products included Tetanus Booster. On 5th June 2018, the patient received the 1st dose of BEXSERO (intramuscular). On 5th June 2018, less than a day after receiving BEXSERO, the patient experienced injection site tenderness. On 6th June 2018, the patient experienced fever. In June 2018, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site tenderness was recovering/resolving. It was unknown if the reporter considered the fever and injection site tenderness to be related to BEXSERO. Additional information was received as follows: The patient also received Tetanus booster (unknown manufacturer) on the same day of vaccination on the left arm but above the injection site for BEXSERO. The patient also received Purified protein derivative (PPD) injection to test for TB on her forearm. The patient's mother reported that the patient received BEXSERO the Tuesday before the day of reporting and experienced a low grade fever the next day. On the same day of vaccination, the patient experienced tenderness on her arm around the injection site. The patient also received Tetanus booster (unknown manufacturer) on the same day of vaccination on the same arm but above the injection site for BEXSERO. The patient also received PPD injection to test for TB on her forearm. The reporter did not wanted to give the next dose in the series due to the adverse event experienced after 1st dose. The patient had denied permission to contact their physician. The call center representative states that patient were twin, received the same series of vaccines on the same day and did not experience the same reaction. The reporter could not provide all details for this report. The patient has denied permission to contact their physician. The reporter stated that they do not intend to give the next dose in the series due to the adverse event experienced after dose 1. The caller stated that this patient's twin received the same series of vaccines on the same day and did not experience the same reaction (refer case US2018104364). Lab Comments: The patient received Purified protein derivative (PPD) injection to test for TB on her forearm.
I woke up with severe abdominal pain. Diagnosed as appendicitis. The surgeon noted that it was severely gangrenous upon removal.  Please note that while one of the causes can just be from hardened fecal matter, I do not have any issues with bowel movements, am regular, and have soft bowel movements.   I did become quite ill with headache, nausea, aches for two and a half days after the second vaccine, and that was my only known illness occurring before the appendicitis. As a virus can cause appendicitis, I wonder if my reaction to vaccine led to this as is was 18 days after the shot. While is was not an immediate event, I would imagine it can take time for an appendix to be affected to the point mine was before it became acute.
According to dad baby had an afebrile seizure the evening shots were administered. Baby taken to ED where baby was admitted to hospital.
Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 11 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Nov2021 16:00 (Lot number: Fk5127) at the age of 11 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15Nov2021, outcome "recovering", described as "Sore arm". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Facility type vaccine: School or Student Health Clinic. No other medication in two weeks or vaccine in four weeks. No Covid prior vaccination and not tested for covid post vaccination.  Follow-up attempts are completed. No further information is expected.
shingles in her eye; This case was reported by a consumer via interactive digital media and described the occurrence of ophthalmic herpes zoster in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the ophthalmic herpes zoster was unknown.   It was unknown if the reporter considered the ophthalmic herpes zoster to be related to Shingles vaccine.  Additional details provided were as follows: The age at vaccination was not reported. The reporter stated that he/she had a customer (patient) who said be warned, she had an eye patch and received a Shingles shot and a week later developed herpes zoster in her eye. The doctor said, she was very lucky because she did not get blind. Follow-up would not be possible as no contact details available.
Sharp pain in both shoulders, Left more than Right. Left shoulder joint and muscle pain persisting still. Interrupting sleep, and coming in waves throughout the day; Not responding well to Tylenol, Ibuprofen or Vicodin. Reported to administering RN, my Chiropractor (2 visits since onset) and my Physician. 01/29/2010 follow up - hoarseness kdr. 1/29/2010 follow up- weakness in arm, wrist and hand. pain in the upper  back. on 12/23/09 i received a diagnosis of parsonage-turner syndrome (brachial nerve injury). 1/15/10 - developed flu-like symptoms or sore throat, runny rose and coughing up yellowish-green sputum. i also noticed that i developed a 1 x 3/4 eruption on the front of my shoulder, near what i call the epicenter of the l shoulder nerve pain.  yesterday a dermatologist diagnosed this  as a wider area rash on my trunk as contact dermatitis and prescribed a steroidal ointment to apply to these areas. they are improving. kdr/
Transcribed from internal reporting system: "Patient was here for a New Patient physical, reviewed immunization history, noted he was due for a Tdap. Discussed vaccine with patient, he agreed to receiving it. Let PCP know he was agreeable to vaccine. When PCP was done with the visit, I was in with the next patient. PCP left a note on my desk that the patient was ready for the vaccine. I checked the chart, vaccine was ordered, patient had left the room and went to lab. I said to the patient, "I have your shot, do you have a preference as to which arm?" he said left and pulled up his sleeve. After the vaccine was given, he asked if it was the Tetanus, I said it was, he then said he had just gotten it. I asked other staff if anyone gave a Tdap, another staff member said PCP had asked her to give the vaccine, so she gave it."  Per PCP note: "He received Tdap vaccines. By error two nurses prepared this vaccine and vaccine was administered 2 times today. He will monitor for adverse symptom, arm pain, skin rash, dizziness and other symptom. He will notify med clinic."
he got a vaccine for covid 19 and got Covid from them; he got a vaccine for covid 19 and got Covid from them; got sick; This is a spontaneous report from a contactable consumer or other non-health professional (reported for nephew) via a Pfizer sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced he got a vaccine for covid 19 and got covid from them and got sick. Reporter stated all he hearing was how safe this vaccine was, and now it was getting mandated. It seems like it was going to be forced on us. Maybe nothing sinister. Reporter questioned can Pfizer Guarantee that if he, his wife and two children receive the vaccine there will be no side effects or adverse reactions. He wanted a guarantee that this was not going to kill or harm anyone in my family. It was being forced from the top down. There seems to be a lot of misinformation about the vaccine, how many people have died and how many had taken it repoter questioned. List of lawsuits involving Pfizer, tons of them that Pfizer has had to pay out. A huge list he was looking at. This information, makes it look like there was a lot of corruption, and kick backs. The amount of censorship and a lot of red flags. Reporter asked how does the vaccine work. Reporter stated he was hearing about a lot of side effects from the vaccine. The patient underwent lab tests and procedures which included Covid: got covid on an unspecified date. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up
pt recv vax 20MAR96 & w/in an hr devel arm swelling that inc over course of day;also had temp of 102-104;seen in AM of 21MAR dx w/toxoid rxn;erythema & edema extended from just above shot site to just below elbow;hyperallergic rxn to vax
Prolonged and heavier menstruation cycles - almost 2 weeks - when normally lasts 7 days
Vaccine administered 9/14/09 at 2:00 p.m.  School nurse reported that patient had a dime size red round reaction yesterday (9/15/09).  Today has a reaction larger than 3 inches, hot to touch some pain.
Pt developed fever, chills, and flu-like symptoms on 12/12/2019 (day after receiving the shot). On 12/15/19, the pt started developing a rash on his right arm. The rash was diagnosed as shingles, and the pt is now receiving antivirals to treat the infection.
This case was reported by a healthcare professional (nurse) and described the occurrence of pertussis in a 5-year-old female subject who was vaccinated with PEDIARIX (GlaxoSmithKline). Concurrent medical conditions included gastroesophageal reflux disease. Concurrent vaccination included PEDVAXHIB (non-gsk); Merck; unknown; unknown given on 15 September 2006 and 20 November 2006; PREVNAR (non-gsk); Wyeth Labs; unknown; unknown given on 15 September 2006, 20 November 2006 and 30 January 2007. Concurrent medications included ZANTAC. On 15 September 2006 at 15:45, 20 November 2006 at 15:45 and 30 January 2007 at 11:00 the subject received 1st dose, 2nd dose and 3rd dose of PEDIARIX (unknown route, left thigh). In October 2011, 5 years after vaccination with PEDIARIX, the subject experienced pertussis cough, chest congestion unspecified, needing to clear throat and vaccination failure. The healthcare professional considered the events were disabling and clinically significant (or requiring intervention). Relevant test results included pertussis identification test positive on 26 October 2011. The subject was treated with ZITHROMAX and codeine. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were possibly related to vaccination with PEDIARIX. This is three of three cases from this reporter. The office has noticed a recent outbreak of pertussis in their area. See A0955333A and A0955529A for details regarding other two cases.
pt recv vax & devel fever, signs showed would bang head against pillow during noc & day;lost weight; dropped from 28lbs to 18lbs slowly; loss appetite; would only drink not eat; lost most of hair; stopped walking & regressed to crawling;sz
weakness, dizziness, shivering, fatigue Began when I got out of bed at 7am. Continued throughout the day.  First day after vaccine, so I don't know if it will continue tomorrow.
First dose of Vaccine did not record in patient system. Patient received second dose on 4/20 Pfizer (Lot ER8732) -   Pt had a PMHx of Anemia, Bursitis, Fractures, and Motion sickness. She presented with left-sided sore throat and left ear pain. Patient had her first Pfizer Covid vaccination on 3/29/2021 to the left upper extremity. Patient noticed enlarged lymph nodes in the left side of her neck few days later. She had an ultrasound of the neck done on 4/13/2021 which demonstrated to supraclavicular enlarged lymph nodes. This past week (4/21) patient developed a left-sided sore throat and noticed that her left tonsil was enlarged. A couple of days ago, she started to feel some pain in her left ear. Per the note, patient received her second Covid vaccination on 4/20 evening. Pt denied significant fevers.
I feel my legs muscles to weak and a lot anxiety attacks; Initial information regarding this unsolicited valid non-serious social media case received from a consumer and transmitted to Sanofi on 18-Oct-2020.  This case is linked to cases 2020SA294157, 2020SA294158 and 2020SA294166 (same source).  This case involved a patient of unknown demographics who experienced got the INFLUENZA VACCINE patient feel my legs muscles to weak and a lot anxiety attacks (anxiety).  Relevant medical history, medical treatment, vaccination details, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient patient feel my legs muscles to weak and a lot anxiety attacks (anxiety), unknown latency following the administration of INFLUENZA VACCINE.  Relevant laboratory test was not reported.  Final diagnosis was patient feel my legs muscles to weak and a lot anxiety attacks.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
Menstrual (Bleeding) does not stop.  Already going on for a few weeks. Slows down as if it's stopping and then comes another flow.
pt recvd vax & 60-90 mins later pt exp nausea, fever, chills, & hyperventilation;
stabbing pain in the back; he can barely walk because of the pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (stabbing pain in the back) and GAIT DISTURBANCE (he can barely walk because of the pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026A21A) for COVID-19 immunisation.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced BACK PAIN (stabbing pain in the back) and GAIT DISTURBANCE (he can barely walk because of the pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (stabbing pain in the back) and GAIT DISTURBANCE (he can barely walk because of the pain) had not resolved.            Concomitant medications were not reported. Patient received Tylenol as treatment medication.
Anosmia. Total loss of sense of smell, going on 5 days now.
Admitted for COVID pna and DKA. Vaccinated x2. Steroids, rocephin, singulair, zinc, O2. Able to wean to RA and dc home.
I got COVID-19 a year after the second vaccine. I started feeling sick 4/26 and tested positive 4/27. My throat was sore I was feeling bad, and I got all the symptoms achy fever. I was coughing so bad I was making myself even sicker and its ongoing. I found out I was pregnant during this COVID-19 on 02/2022.
Pain, tenderness and swelling at injection site. Fatigue, headache, muscle pain, joint pain, chills, nausea, vomiting, dizziness, weakness, fast heartbeat
administration of Shingrix at 56 day.; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th October 2022, the patient received the 2nd dose of Shingrix. On 20th October 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 20-Oct 2022 Reporter's comment: The pharmacist reported the administration of Shingrix at 56 days mark to the patient. The reporter consented to follow-up. Additional supportive information: The patient received 2nd dose of Shingrix earlier than the recommended interval, which led to shortening of vaccine schedule. As per reported information it seems that the reporter was reporting about second dose therefore case was kept valid for second dose and meanwhile query raised for the clarification.
Hives, rash, itching, eyes swollen Saturday morning, 2/6/10. Right eye swollen for approx. 1:45 min 2/8/10.
This spontaneous report as received from a nurse practitioner refers to a 74 year old female patient with sulfa allergy. The patient's medical history included chickenpox as a child. On 21-JAN-2009 the patient was vaccinated with ZOSTAVAX (lot # 663639/1707X, expiration date 26-MAY-2010) (dose and route were not reported) for vaccination. There were not concomitant medications. The nurse practitioner reported that, on 14-FEB-2014, patient developed shingles following vaccination with ZOSTAVAX. The nurse practitioner described the shingles as a maculopapular rash on the right flank, which was the patient's first case of shingles. No lab diagnostics studies were performed. Patient received FAMVIR as treatment for the adverse event. Patient sought medical attention: contacted nurse practitioner. The outcome of shingles was reported as not recovered/not resolved. The relationship between ZOSTAVAX and the event was not reported. Additional information has been requested.
developed a red patch on injection site; patch is hard in the middle; patch is warm like feverish; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (developed a red patch on injection site), VACCINATION SITE INDURATION (patch is hard in the middle) and VACCINATION SITE WARMTH (patch is warm like feverish) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Cholesterol and Anxiety. Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (developed a red patch on injection site), VACCINATION SITE INDURATION (patch is hard in the middle) and VACCINATION SITE WARMTH (patch is warm like feverish). At the time of the report, VACCINATION SITE ERYTHEMA (developed a red patch on injection site), VACCINATION SITE INDURATION (patch is hard in the middle) and VACCINATION SITE WARMTH (patch is warm like feverish) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
syncope; POTS; This spontaneous report was received from a lawyer regarding a case in litigation concerning a 12-year-old female patient (pt). Information on the pt's concurrent conditions, medical history or concomitant therapy was not reported. On an unknown date, the pt was vaccinated with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (dose, route of administration, lot# and expiration date were not reported) for prophylaxis. Following vaccination, in 2013, the pt experienced Postural orthostatic tachycardia syndrome (POTS) and syncope. The outcome of the events was not provided. The reporter stated that the events were deemed or should had been deemed causally related to Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) vaccination. This is one of multiple cases from the same reporter.  Upon internal review, Syncope was considered a medically significant event.; Sender's Comments:  US-009507513-2301USA006946:
At 17:00, started with temperature of 103.5F. 101.9F (ax). Irritable. Given Motrin and temperature went away and down in the morning.
Syncope with fall to ground. Patient was assisted to sitting and provided orange juice and additional sugar. No other management details available. Patient discharged to home and subsequent notes in EMR suggest full recovery.
Hives, first bump within 24 hours on the arm near the site of injection with three more to follow over the next 2-3 days
Patient reported sore arm; they administered a patient with flu shot and Spikevax using same needle but not the same syringe (caller did not know if Spikevax was administered first or vice versa), because the needle stayed into the patient in between shots.; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (Patient reported sore arm) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (they administered a patient with flu shot and Spikevax using same needle but not the same syringe (caller did not know if Spikevax was administered first or vice versa), because the needle stayed into the patient in between shots.) in an adult patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 8058581) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    The patient had not known medical history/conditions, allergy, concomitant diseases and risk factor. The patient had received other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 12-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) .5 milliliter and dose of INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) (unknown route) 1 dosage form. On 12-Oct-2023, the patient experienced PAIN IN EXTREMITY (Patient reported sore arm) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (they administered a patient with flu shot and Spikevax using same needle but not the same syringe (caller did not know if Spikevax was administered first or vice versa), because the needle stayed into the patient in between shots.). At the time of the report, PAIN IN EXTREMITY (Patient reported sore arm) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (they administered a patient with flu shot and Spikevax using same needle but not the same syringe (caller did not know if Spikevax was administered first or vice versa), because the needle stayed into the patient in between shots.) outcome was unknown.        For mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was reported that they administered a patient with flu shot and Spikevax using same needle but not the same syringe (caller did not know if Spikevax was administered first or vice versa), because the needle stayed into the patient in between shots. Patient reported sore arm. No treatment medication was reported.